OKYO logo

OKYO Pharma Limited (OKYO) Financials

Balance sheets

Sep 1, 2024Mar 1, 2024Mar 31, 2023Sep 30, 2022Mar 31, 2022Sep 30, 2021Mar 31, 2021Sep 30, 2020Mar 31, 2020Sep 30, 2019Mar 31, 2019Sep 30, 2018Mar 31, 2018Sep 30, 2017Mar 31, 2017

Total Assets

$2.8 M(+83.5%)$1.5 M(-70.4%)$5.2 M(+193.3%)$1.8 M(-58.7%)$4.3 M(-23.3%)$5.6 M(-20.9%)$7.1 M(-5.6%)$7.5 M(+1157.6%)$597.4 K(-3.1%)$616.7 K(-18.8%)$759.9 K(-53.7%)$1.6 M(-41.7%)$2.8 M(-27.0%)$3.9 M(-94.4%)$68.7 M

Current Assets

$2.8 M(+83.8%)$1.5 M(-70.4%)$5.2 M(+193.8%)$1.8 M(-58.8%)$4.3 M(-22.2%)$5.5 M(-21.0%)$7.0 M(-6.6%)$7.5 M(+1220.4%)$566.7 K(-8.0%)$615.9 K(-18.8%)$758.8 K(-53.8%)$1.6 M(-41.7%)$2.8 M(-25.9%)$3.8 M(-94.5%)$68.7 M

Non Current Assets

$2200.0(-35.3%)$3400.0(-52.8%)$7200.0(+28.6%)$5600.0(+7.7%)$5200.0(-93.9%)$85.8 K(-18.0%)$104.6 K(+245.2%)$30.3 K(-1.3%)$30.7 K(+3737.5%)$800.0(-27.3%)$1100.0(+100.0%)$0.0(0%)$0.0(-100.0%)$57.0 K(+100.0%)$0.0

Total Liabilities

$10.1 M(+35.5%)$7.4 M(+2.3%)$7.3 M(+242.3%)$2.1 M(+56.7%)$1.4 M(+103.7%)$664.4 K(-62.5%)$1.8 M(+301.9%)$440.9 K(-40.2%)$737.2 K(-9.3%)$812.5 K(+90.4%)$426.7 K(+95.6%)$218.1 K(+70.9%)$127.6 K(-59.6%)$315.6 K(+45.6%)$216.7 K

Current Liabilities

$10.1 M(+35.5%)$7.4 M(+2.3%)$7.3 M(+242.3%)$2.1 M(+56.7%)$1.4 M(+119.2%)$617.3 K(-63.8%)$1.7 M(+309.3%)$417.1 K(-41.3%)$710.7 K(-12.5%)$812.5 K(+90.4%)$426.7 K(+95.6%)$218.1 K(+70.9%)$127.6 K(-59.6%)$315.6 K(+45.6%)$216.7 K

Long Term Liabilities

$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(-100.0%)$47.1 K(-27.1%)$64.6 K(+171.4%)$23.8 K(-10.2%)$26.5 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Shareholders Equity

-$7.2 M(-22.9%)-$5.9 M(-186.4%)-$2.1 M(-493.8%)-$345.8 K(-111.7%)$2.9 M(-40.4%)$4.9 M(-7.1%)$5.3 M(-24.8%)$7.1 M(+5158.7%)-$139.8 K(+28.6%)-$195.8 K(-158.8%)$333.1 K(-76.6%)$1.4 M(-47.0%)$2.7 M(-24.1%)$3.5 M(-94.8%)$68.5 M

Book Value

-$7.2 M(-22.9%)-$5.9 M(-186.4%)-$2.1 M(-493.8%)-$345.8 K(-111.7%)$2.9 M(-40.4%)$4.9 M(-7.1%)$5.3 M(-24.8%)$7.1 M(+5158.7%)-$139.8 K(+28.6%)-$195.8 K(-158.8%)$333.1 K(-76.6%)$1.4 M(-47.0%)$2.7 M(-24.1%)$3.5 M(-94.8%)$68.5 M

Working Capital

-$7.2 M(-22.9%)-$5.9 M(-185.5%)-$2.1 M(-486.4%)-$351.4 K(-111.9%)$2.9 M(-40.0%)$4.9 M(-7.1%)$5.3 M(-25.3%)$7.1 M(+5006.6%)-$144.0 K(+26.8%)-$196.6 K(-159.2%)$332.1 K(-76.7%)$1.4 M(-47.0%)$2.7 M(-22.8%)$3.5 M(-94.9%)$68.5 M

Cash And Cash Equivalents

$987.2 K(+19.4%)$826.8 K(-79.6%)$4.0 M(+471.7%)$707.6 K(-73.8%)$2.7 M(-47.8%)$5.2 M(-25.0%)$6.9 M(-7.0%)$7.4 M(+3053.9%)$235.0 K(+249.7%)$67.2 K(-89.3%)$627.6 K(-61.3%)$1.6 M(-42.4%)$2.8 M(-21.2%)$3.6 M(-4.7%)$3.7 M

Accounts Payable

$8.7 M(+42.2%)$6.1 M(+164.8%)$2.3 M(+52.0%)$1.5 M(+105.3%)$741.8 K(+244.1%)$215.6 K(+2.2%)$211.0 K(-36.4%)$331.6 K(-44.1%)$593.7 K(-23.8%)$778.8 K(+104.0%)$381.8 K(+226.1%)$117.1 K(+100.0%)$0.0(-100.0%)$291.6 K(+105.6%)$141.8 K

Accounts Receivable

--------------$0.0

Short Term Debt

$1800.0-$2.2 M(+100.0%)$0.0-$34.4 K(+0.9%)$34.1 K(+568.6%)$5100.0(0%)$5100.0-$0.0----

Long Term Debt

---$0.0-$47.1 K(-27.1%)$64.6 K(+171.4%)$23.8 K(-10.2%)$26.5 K-$0.0----

Total Debt

$1800.0(+100.0%)$0.0(-100.0%)$2.2 M(+100.0%)$0.0(0%)$0.0(-100.0%)$81.5 K(-17.4%)$98.7 K(+241.5%)$28.9 K(-8.5%)$31.6 K(+100.0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0(0%)$0.0

Debt To Equity

0.0(0%)0.0(+100.0%)-1.1(-100.0%)0.0(0%)0.0(-100.0%)0.0(0%)0.0(+100.0%)0.0(+100.0%)-0.2(-100.0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0(0%)0.0

Current Ratio

0.3(+33.3%)0.2(-70.8%)0.7(-13.3%)0.8(-73.8%)3.2(-64.6%)8.9(+118.8%)4.1(-77.2%)17.9(+2142.5%)0.8(+5.3%)0.8(-57.3%)1.8(-76.3%)7.5(-65.9%)22.1(+83.3%)12.0(-96.2%)317.0

Quick Ratio

---------------

Inventory

---------------

Retained Earnings

-$145.2 M(-1.9%)-$142.5 M(-13.4%)-$125.7 M(-38.3%)-$90.9 M(+19.1%)-$112.4 M(-12.5%)-$100.0 M(+5.7%)-$106.0 M(-17.1%)-$90.6 M(-5.5%)-$85.9 M(-1.1%)-$84.9 M(+4.5%)-$89.0 M(-4.0%)-$85.5 M(+5.3%)-$90.3 M(-6.1%)-$85.1 M(-499.8%)-$14.2 M

PB Ratio

-5.4(+30.9%)-7.9(+81.3%)-42.0(+74.6%)-165.6-----------

Income statements

Sep 1, 2024Mar 1, 2024Mar 31, 2023Sep 30, 2022Mar 31, 2022Sep 30, 2021Mar 31, 2021Sep 30, 2020Mar 31, 2020Sep 30, 2019Mar 31, 2019Sep 30, 2018Mar 31, 2018Sep 30, 2017Mar 31, 2017

EPS

---------------

TTM EPS

---------------

Revenue

---------------

TTM Revenue

---------------

Total Expenses

---------------

Operating Expenses

---------------

Cost Of Goods Sold

---------------

TTM Cost Of Goods Sold

---------------

Gross Profit

---------------

TTM Gross Profit

---------------

Gross Margin

---------------

Operating Profit

---------------

TTM Operating Profit

---------------

Operating Margin

---------------

Net Income

---------------

TTM Net Income

---------------

Net Margin

---------------

EBIT

---------------

TTM EBIT

---------------

EBITDA

---------------

TTM EBITDA

---------------

Selling, General & Administrative Expenses

---------------

TTM SGA

---------------

Depreciation And Amortization

---------------

TTM D&A

---------------

Interest Expense

---------------

TTM Interest Expense

---------------

Income Tax

---------------

TTM Income Tax

---------------

PE Ratio

---------------

PS Ratio

---------------

Cashflow statements

Sep 1, 2024Mar 1, 2024Mar 31, 2023Sep 30, 2022Mar 31, 2022Sep 30, 2021Mar 31, 2021Sep 30, 2020Mar 31, 2020Sep 30, 2019Mar 31, 2019Sep 30, 2018Mar 31, 2018Sep 30, 2017Mar 31, 2017

Cash From Operations

---------------

TTM CFO

---------------

Cash From Investing

---------------

TTM CFI

---------------

Cash From Financing

---------------

TTM CFF

---------------

Free Cash Flow

---------------

TTM FCF

---------------

CAPEX

---------------

TTM CAPEX

---------------

Dividends Paid

---------------

TTM Dividends Paid

---------------

TTM Dividend Per Share

---------------

TTM Dividend Yield

---------------

Payout Ratio

---------------